Who is a good candidate for FOLFOX adjuvant chemotherapy?

This regimen is primarily indicated for patients with stage III colorectal cancer after surgical resection to reduce the risk of recurrence. It may also be considered for high-risk stage II patients. Contraindications include severe peripheral neuropathy, significant kidney impairment, or a history of allergic reactions to platinum-based drugs. Your oncologist will assess your overall health and tumor characteristics to determine suitability.